We are live on ! Find out more
AMRX icon

Amneal Pharmaceuticals
AMRX

277 hedge funds and large institutions have $1.95B invested in Amneal Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 100 increasing their positions, 80 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

611% more call options, than puts

Call options by funds: $7.01M | Put options by funds: $985K

128% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 25

29% more capital invested

Capital invested by funds: $1.51B → $1.95B (+$437M)

25% more repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 80

12% more funds holding

Funds holding: 248 → 277 (+29)

1.15% more ownership

Funds ownership: 48.01% → 49.17% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

Holders
277
Holders Change
+29
Holders Change %
+11.69%
% of All Funds
3.37%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
57
Increased
100
Reduced
80
Closed
25
Calls
$7.01M
Puts
$985K
Net Calls
+$6.02M
Net Calls Change
-$921K

Top Buyers

1
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$18.4M
2
Morgan Stanley
Morgan Stanley
New York
+$15M
3
PHS
PFM Health Sciences
California
+$12.7M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$12.5M
5
PCM
Penn Capital Management
Pennsylvania
+$11.5M

Top Sellers

1
NCM
Nantahala Capital Management
Connecticut
-$20.3M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$17.5M
3
Deutsche Bank
Deutsche Bank
Germany
-$9.56M
4
Prudential Financial
Prudential Financial
New Jersey
-$8.48M
5
Walleye Capital
Walleye Capital
New York
-$8M
Name Holding Trade Value Shares
Change 		Change in
Stake
EWA
226
EverSource Wealth Advisors
Alabama
$20.4K +$366 +32 +2%
BNP Paribas Asset Management
227
BNP Paribas Asset Management
France
$18K +$5.17K +452 +47%
Osaic Holdings
228
Osaic Holdings
Arizona
$17.8K -$10.4K -912 -39%
AF
229
Allworth Financial
California
$13.5K +$1.71K +149 +16%
TFA
230
Toth Financial Advisory
Virginia
$12.6K – – –
Daiwa Securities Group
231
Daiwa Securities Group
Japan
$12K -$1.03K -90 -9%
National Bank of Canada
232
National Bank of Canada
Quebec, Canada
$10.9K -$46 -4 -0.5%
FFO
233
Fortitude Family Office
Arizona
$10.2K +$263 +23 +3%
CWMS
234
CFG Wealth Management Services
Indiana
$10.1K +$9.15K +800 New
IA
235
IFP Advisors
Florida
$8.68K +$240 +21 +3%
MPWT
236
MassMutual Private Wealth & Trust
Connecticut
$8.21K – – –
ACM
237
Accent Capital Management
Ohio
$7.56K +$6.87K +600 New
GI
238
GAMMA Investing
California
$7.07K +$709 +62 +12%
AAP
239
Arax Advisory Partners
Colorado
$6.55K -$240K -20,965 -98%
PNC Financial Services Group
240
PNC Financial Services Group
Pennsylvania
$6.45K +$149 +13 +3%
MW
241
Merited Wealth
Florida
$6.43K +$5.83K +510 New
MSFP
242
Mark Sheptoff Financial Planning
Connecticut
$6.3K +$5.72K +500 New
US Bancorp
243
US Bancorp
Minnesota
$4.61K – – –
RFP
244
Root Financial Partners
California
$4.27K +$1.54K +135 +66%
CT
245
Colonial Trust
South Carolina
$3.88K – – –
Optiver Holding
246
Optiver Holding
Netherlands
$3.38K -$6.68K -584 -69%
SFG
247
Strive Financial Group
Indiana
$3.15K +$2.86K +250 New
FFA
248
Farther Finance Advisors
California
$3.14K +$1.14K +100 +67%
Bessemer Group
249
Bessemer Group
New Jersey
$3K – – –
KG
250
Kilter Group
New York
$2.09K +$1.9K +166 New
8 9
10
11 12

AMRX Hedge Fund Activity: Q4 2025 in Review

277 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Amneal Pharmaceuticals (AMRX) for Q4 2025, worth a combined $1.95B — up 29% from $1.51B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new AMRX positions and 25 closed out — a net gain of 32 holders — while 100 added to existing stakes and 80 trimmed.

The largest buyer was Assenagon Asset Management, adding an estimated $18.4M. The largest seller was Nantahala Capital Management, cutting an estimated $20.3M.

  • 277 institutional investors held Amneal Pharmaceuticals (AMRX) as of Q4 2025, up from 248 in Q3 2025.
  • Funds reported $1.95B of Amneal Pharmaceuticals stock for Q4 2025, up 29% quarter-over-quarter.
  • 57 funds opened new Amneal Pharmaceuticals positions in Q4 2025 and 25 closed out, a net change of +32 holders.
  • The largest Amneal Pharmaceuticals buyer in Q4 2025 was Assenagon Asset Management, an estimated $18.4M added.
  • The largest Amneal Pharmaceuticals seller in Q4 2025 was Nantahala Capital Management, an estimated $20.3M sold.

Based on aggregated 13F filings for Q4 2025.